Ninety One’s Idexx Laboratories IDXX Stock Holding History

Ninety One’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,905	Closed	-$1.22M	–	98
2025 Q3	$1.22M	Sell	1,905 -4,317	-69%	-$2.62M	0.05%	66
2025 Q2	$3.34M	Buy	6,222 +214	+4%	+$102K	0.55%	43
2025 Q1	$2.52M	Buy	6,008 +1,551	+35%	+$673K	0.47%	44
2024 Q4	$1.84M	Buy	4,457 +341	+8%	+$150K	0.41%	47
2024 Q3	$2.08M	Hold	4,116	–	–	0.45%	47
2024 Q2	$2.01M	Hold	4,116	–	–	0.31%	48
2024 Q1	$2.22M	Hold	4,116	–	–	0.32%	50
2023 Q4	$2.28M	Hold	4,116	–	–	0.35%	50
2023 Q3	$1.8M	Hold	4,116	–	–	0.35%	46
2023 Q2	$2.07M	Hold	4,116	–	–	0.51%	40
2023 Q1	$2.06M	Hold	4,116	–	–	0.52%	43
2022 Q4	$1.68M	Buy	+4,116	New	+$1.6M	0.55%	41

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ninety One's IDXX Position: Q4 2025 in Review

Ninety One sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 1,905 shares — an estimated $1.22M sold.

Ninety One first reported a position in IDXX in Q4 2022 and held it in 12 quarters. The position peaked at $3.34M in Q2 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Ninety One reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Ninety One sold 1,905 Idexx Laboratories shares in Q4 2025, an estimated $1.22M.
Ninety One first reported a position in Idexx Laboratories in Q4 2022 and held it in 12 quarters.
Ninety One's Idexx Laboratories position peaked at $3.34M in Q2 2025.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Ninety One's 13F filing for Q4 2025, filed 27 Jan 2026.